Ekso Bionics Holdings, Inc. (EKSO)

US — Healthcare Sector
Peers: PDEX  CLPBY  OPSSF  SAUHY  NEPH  INFU  POCI  MLSS  FEMY  LMAT  UTMD  GMVD  ATRI  GCTK  AKYA 

Automate Your Wheel Strategy on EKSO

With Tiblio's Option Bot, you can configure your own wheel strategy including EKSO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol EKSO
  • Rev/Share 0.6909
  • Book/Share 0.4998
  • PB 8.543
  • Debt/Equity 0.4426
  • CurrentRatio 2.3463
  • ROIC -0.5209

 

  • MktCap 10248000.0
  • FreeCF/Share -0.3298
  • PFCF -1.2238
  • PE -10.0471
  • Debt/Assets 0.2057
  • DivYield 0
  • ROE -0.825

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 4
  • P/B Score 4
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 – Conference Call to Follow
EKSO
Published: February 24, 2025 by: GlobeNewsWire
Sentiment: Neutral

SAN RAFAEL, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2024 after the close of trading on Monday, March 3, 2025. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to review the financial results and discuss recent business developments.

Read More
image for news Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 – Conference Call to Follow
NSM Named Exclusive Distributor of Ekso Indego® Personal Within the CRT Industry
EKSO
Published: February 10, 2025 by: GlobeNewsWire
Sentiment: Neutral

Move expected to broaden access to Ekso Bionics' portable exoskeleton device for individuals living with spinal cord injuries and other mobility challenges across the United States Move expected to broaden access to Ekso Bionics' portable exoskeleton device for individuals living with spinal cord injuries and other mobility challenges across the United States

Read More
image for news NSM Named Exclusive Distributor of Ekso Indego® Personal Within the CRT Industry

About Ekso Bionics Holdings, Inc. (EKSO)

  • IPO Date 2014-01-17
  • Website https://www.eksobionics.com
  • Industry Medical - Instruments & Supplies
  • CEO Mr. Scott G. Davis
  • Employees 61
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.